VBI Vaccines
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, VBI Vaccines sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
VBI Vaccines: 4 sponsored US clinical trials, 2 recruiting.
VBI Vaccines sponsors 4 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 2 completed. 2 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Vaccine Exposure During Pregnancy, with 1 trials.
Upper-quartile sponsor footprint
VBI Vaccines sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
4 total, page 1 of 1
PREHEVBRIO Pregnancy Outcomes Registry
NCT06097312
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
NCT03382977
Lot-to-lot Consistency of Sci-B-Vac™ in Adults
NCT03408730
Immunogenicity and Safety of Sci-B-Vac® to Engerix-B® in Adults
NCT03393754
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 3 | 2 |
Therapeutic Areas
Where VBI Vaccines enrollment is open (later-stage tilt)
2 recruiting of 4 indexed (50% open); 2 completed (50%).
Phase mix: 2 late (III/IV) vs 1 early (I/II) (later-stage heavy).
Top condition: Vaccine Exposure During Pregnancy (1 trial), 1 other listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
VBI Vaccines: open-pipeline peers nationwide
Peers matched on 4 registered trials and 50% open enrollment, not the therapeutic-area sidebar.
VBI Vaccines sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 trials (± recruiting share)
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors near 50% open enrollment (± trial volume)
- 1200 Pharma · 50% recruiting · 2 trials
- 1ST Biotherapeutics · 50% recruiting · 2 trials
- 3ive Labs · 50% recruiting · 2 trials
- 7 Hills Pharma · 50% recruiting · 2 trials
Related
What to do with this VBI Vaccines page
4 registered trials is a research-attention snapshot, not an endorsement of VBI Vaccines or any single study.
- 2 of VBI Vaccines's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Vaccine Exposure During Pregnancy is the condition VBI Vaccines studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Vaccine Exposure During Pregnancy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. VBI Vaccines pipeline card: 4 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.